CompletedNot Applicable

"Gluten Friendly" Treatment in Celiac Disease

Italy45 participantsStarted 2017-03-20

Plain-language summary

A PROSPECTIVE, double blind, placebo-controlled trial

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * celiac patients with positive antitransglutaminase and histology compatible with celiac disease Exclusion Criteria: * positive antitransglutaminase at enrollment

What they're measuring

Measure of small bowel mucosal density and evaluation of the serologic markers of celiac disease

Timeframe: Three months after of treatment

Trial details

NCT IDNCT03137862

SponsorCasa Sollievo della Sofferenza IRCCS

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-04-02

View on ClinicalTrials.gov More Food Intolerance trials